“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: P.55 Expression of the hemogenic transcription factor Runx1 in in vitro generated hematopoietic progenitor cells

€2.42

SKU: product-article-21274 Category: General

Description
Reviews (0)

Description

P.55 Expression of the hemogenic transcription factor Runx1 in in vitro generated hematopoietic progenitor cells

Reviews

There are no reviews yet.

Be the first to review “Article: P.55 Expression of the hemogenic transcription factor Runx1 in in vitro generated hematopoietic progenitor cells”

Top

Article: P.55 Expression of the hemogenic transcription factor Runx1 in in vitro generated hematopoietic progenitor cells

Description

Reviews

Related products

Article: Highlights in breast cancer

Article: INTRODUCTION

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: Highlights in genitourinary cancers